Highly Active Antiretroviral Therapy: Pharmacoeconomic Issues in the Management of HIV Infection

By Sendi P.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 709-713

Adis International

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection: What Are the Issues and What Can Be Done?

By Pontali Emanuele  

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 137-149

Adis International

Access to resources Recommend Favorite

Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients

By Lamiraud Karine   Moatti Jean-Paul  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

By Calza L.   Manfredi R.   Chiodo F.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 2, 2003-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite